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Summary: Insulin causes a 5 to lo-fold increase in the velocity of a-amino- 
isobutyric acid transport and a 2 to 3-fold increase in tyrosine amino- 
transferase activity in dexamethasone-treated hepatoma tissue culture cells. 
Maximal responses occur 2-4 hours after insulin addition but then decrease 
to control levels by 24 hours incubation. Medium conditioned by cells 
incubated with insulin for 24 hours retains sufficient biologically active 
insulin to produce an insulin response in fresh dexamethasone-treated cells. 
Readdition of insulin to insulin-treated cells, however, elicits no response, 
indicating that the cells are insensitive to the hormone. Incubation of 
such unresponsive cells in the absence of insulin results in recovery of 
responsiveness within 2 hours. These data suggest that exposure of rat 
hepatoma cells to insulin causes a complete but reversible loss of sensi- 
tivity to this hormone. 
Hepatoma tissue culture (HTC) 1 cells, an established line of rat hepatoma 
cells, respond to dexamethasone with a 5 to lo-fold increase in the cellular 
concentration of tyrosine aminotransferase (TAT) (E.C. 2.6.1.5) (11 and a 
90% inhibition in the initial rate of a-aminoisobutyric acid (AIB) transport 
(2,3). Addition of insulin to HTC cells, treated with dexamethasone for 16-18 
hours, results in a further 2 to 3-fold increase in TAT (4,5) and 5 to lo-fold 
increase in AIB transport velocity (2). Maximal transport velocity and trans- 
aminase activity occur 2 hours and 3-4 hours after insulin addition, respec- 
tively. As we show in this communication, both effects then decay despite 
the continued presence of insulin, and by 24 hours of incubation with insulin 
transaminase activity and AIB transport velocity have returned to a level 
similar to that in cells treated with dexamethasone alone. The present study 
was undertaken to explain this response of HTC cells to chronic insulin exnosure 
1. The abbreviations used are: HTC, hepatoma tissue culture; TAT, 
tyrosine aminotransferase; AIB, cc-aminoisobutyric acid; MSA, 
multiplication stimulating activity. 
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METHODS: 
Cells: HTC cells were grown in spinner culture in modified Eagle's 
Minimal Essential Medium without antibiotics as described previously (6). 
Cells in the logarithmic phase of growth were harvested by centrifugation 
and resuspended at 0.8 - 1.0 x lo6 cells per ml in serum-free medium con- 
taining 50 us/ml neomycin and 0.1% BSA (IM-BSA). Incubations were carried 
out in suspension cultures in a gyrotory shaker water bath at 37'C. At 
least 95% of the cells, excluded trypan blue after 50 hours incubation 
in serum-free medium. 
TAT Assay: As described in the legends to the figures, samples of 
cells were removed from the suspension culture and centrifuged at 1200 x g 
for 2 min. The cell pellets were washed with 0.1 M potassium phosphate 
buffer, pH 7.6, and stored as pellets at -20°C. Assays of TAT specific 
activity were carried out as previously described (7). TAT specific activity 
is reported as munits/mg soluble protein. One munit catalyzes the formation 
of one nmole p-hydroxyphenylpyruvate per minute at 37OC. 
AIB Transport: The initial rate of AIB transport was determined as 
described by Heaton and Gelehrter (5). The assay was carried out for 10 
min with 0.5 mM AIB including 0.25 uCi/ml 14C-AIB. Radioactivity con- 
tributed by trapped water was determined by addition of r3H]-inulin 30 
set before stopping the reaction. Protein content was determined by the 
method of Lowry, et al., (8). 
Radioimmunoassay of Insulin: Radioinrnunoassay of insulin in culture 
medium was kindly performed by the Ligand Core Laboratory of the Michigan 
Diabetes Research and Training Center, according to the method of Hayashi, 
et. al - --' (9) - 
Materials: Insulin was a gift from Dr. R. E. Chance, Eli Lilly Company. 
:e;yf$ 
asone was a gift from Dr. Walter Gall of Merck and Company. 
Cl-aminoisobutyric acid (specific activity 45-52 mCi/mM) was purchased 
from New England Nuclear and r3Hl-inulin (approx. 800 mCi/mM) was purchased 
from Amersham. 
RESULTS 
Fig. 1A illustrates the time course of insulin induction of TAT in dex- 
amethasone-treated HTC cells. In this experiment incubation of cells for 17 
hours with 0.1 uM dexamethasone increased TAT activity 6-fold. Addition of 
4 ug/ml insulin resulted in a further 2-fold increase in TAT specific activity 
at 3 hours, after which the TAT activity decreased so that by 24 hours of 
exposure to insulin, TAT specific activity was nearly identical to that of 
cells incubated with dexamethasone alone. 
A similar phenomenon is seen when one examines insulin enhancement of 
AIB transport. In the experiment shown in Fig. lB, dexamethasone inhibited 
AIB transport by 82% after 18 hours incubation. The addition of insulin 
(4 ug/ml) to dexamethasone-treated cells stimulated transport nearly 8-fold. 
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Fig. 1. Time course of insulin stimulation of TAT activity and AIB transport. 
HTC cells were incubated in suspension culture in IM-BSA containing 0.1 uM 
dexamethasone for 17 hours. The cells were then divided into two portions, 
and to one insulin was added to a final concentration of 4 us/ml. The other 
portion was used as control. At the times indicated samples were taken for 
assay of TAT (Part A) or for assay of initial rates of AIB transport (Part B). 
(0) dexamethasone alone 
CO) dexamethasone + insulin at 0 time 
Insulin-stimulated transport is maximal after 2 hours incubation and then 
decreases. Again, after 24 hours in insulin-containing medium, these cells 
transport AIB at a rate similar to that of cells incubated with dexamethasone 
alone. 
Since liver cells degrade insulin, it is possible that the loss of 
insulin response is due to degradation of the insulin in the medium. Three 
lines of evidence argue against this explanation. 
Padioirmnunoassays were performed to determine the concentration of 
insulin in the medium after O-24 hours in incubation with cells. The results 
of a representative experiment are shown in Table I. After 4 hours incubation, 
a time at which the rate of amino acid transport has decreased (Fig. l), little 
insulin has been degraded. At 12 and 24 hours, however, the insulin concentration 
is significantly decreased. We have shown previously that a maximal insulin 
response is routinely achieved with an insulin concentration of 1 pg/ml 
and can be obtained with concentrations as low as 200 rig/ml. Half-maximal 
response is seen at 35 rig/ml insulin (10). Therefore, at 12 hours of incubation 
the remaining 1.2 vg/ml insulin should be sufficient to produce a maximal 
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TABLE I 
Degradation of Insulin by HTC Cells 
A B C D 
Time of Incubation Insulin Concentration TAT Induction AIB Transport 
w/ml (Percent Increase) 
0 3950 124 917 
2 3820 122 917 
4 3890 106 896 
6 2840 103 754 
12 1200 104 708 
24 84 51 333 
HTC cells were incubated for 17 hours with 0.1 uM dexamethasone. The culture 
was then divided into two portions, and to one insulin was added to a final 
concentration of 4 pg/ml. At the times indicated after insulin addition 
(Column A), a portion of the culture was centrifuged to remove cells. The 
insulin concentration of the medium was determined by radioimmunoassay (Column B). 
This conditioned medium was also tested for its insulin action by measuring 
TAT activity (Column C) and AIB transport velocity (Column D) in fresh 
dexamethasone-treated cells incubated in the conditioned medium for 4 or 2 
hours, respectively. 
response. Even at 24 hours sufficient immunoreactive insulin (84 rig/ml) 
remains in the medium to elicit at least a partial response. 
The following experiment established that the insulin remaining in the 
medium is biologically potent. Dexamethasone-treated HTC cells were incubated 
with 4 I-g/ml insulin and at times from O-24 hours the cells were removed from 
a portion of the culture by centrifugation. The conditioned medium was then 
tested for its ability to induce TAT and to stimulate AIB transport in fresh 
dexamethasone-treated cells. The results are shown in Table 1. Conditioned 
medium from incubations of up to 12 hours evoke a nearly maximal response, 
whereas conditioned medium from a 24-hour incubation is less potent. This 
is consistent with the insulin concentration as determined by radioimmunoassay. 
After 12 hours incubation, when the insulin effect has significantly decreased 
(Fig. 11, sufficient biologically active hormone remains to produce a nearly 
maximal response. Even after 24 hours incubation, when the insulin response 
is totally lost, the medium is capable of producing at least a partial response 
Thus the decay of the insulin response observed in Fig. 1 is not due simply 
to degradation of insulin. 
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Thirdly, we examined the ability of insulin-treated cells to respond to 
additional hormone. As illustrated in Fig. 2, readdition of 4 pg/ml insulin 
to cells which have been incubated with insulin for 24-26 hours does not elicit 
a response,indicating that these cells have become completely unresponsive to 
insulin. Cells incubated in dexamethasone-containing, insulin-free medium 
for the same time period show a full response to added insulin, indicating that 
cells in serum-free medium for that period of time are viable and responsive. 
The data are consistent with the hypothesis that exposure of HTC cells to 
insulin causes a complete loss of responsiveness to this hormone. 
Insulin-induced insensitivity to insulin in HTC cells is reversible, as 
shown in Fig. 3. Cells rendered insulin-insensitive by a 24 hour incubation 
with the hormone, were centrifuged out of the medium and washed to remove 
insulin. The cells were then resuspended in dexamethasone-containing medium 
and incubated at 37OC. Immediately after (‘0’ time), and 2 hours after the 
wash procedure 4 uq/ml insulin was again added to a portion of the cells. 
Within 2 hours, cells in insulin-free medium have recovered full responsiveness. 
When insulin was added immediately after the wash procedure, there was a 
short lag and a blunted response to insulin. Since the wash procedure 
takes about 20 min and since recovery is rapid, this may reflect a partial 
recovery. The lag is not caused by the wash procedure itself as dexamethasone- 
treated cells, washed immediately before insulin addition, exhibit a normal 
response to insulin (results not shown). A more rapid wash (5 min) can be 
accomplished in monolayer cultures. Cells in monolayer,which have been 
desensitized to insulin by a 24 hour incubation with the hormone, do not 
respond to insulin which is readded immediately after the wash procedure 
(data not shown). 
DISCUSSION: 
HTC cells display specific membrane receptors for insulin and for the 
insulin-like growth factor,multiplication stimulating activity (MSA). Since 
insulin does not bind to the MSA receptor, even at concentrations as high as 
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Fig. 2. Insulin responsiveness in HTC cells after chronic exposure to insulin. 
HTC cells were incubated in suspension culture in IM-BSA containing 0.1 UM 
dexamethasone for 17 hours. The cells were then divided into two portions, 
and to one insulin was added to a final concentration of 4 Uq/ml. The other 
portion was used as control. Incubation continued for 24 to 26 hours, at which 
time each culture was again divided into two portions. To one of each pair 
was added 4 ug/ml fresh insulin. In this figure '0' time represents a total 
of 41-43 hours preincuhation. At the times indicated samples were taken for 
assay of TAT (Part A) or AIB transport (Part B). 
(0) dexamethasone alone for total incubation 
(0) dexamethasone 17 hours + insulin for 24-26 hours 
(0) dexamethasone 41-43 hours + insulin at '0' time 
(I) dexamethasone 17 hours + insulin for 24-26 hours + insulin again 
at '0' time 
Fig. 3. Recovery of insulin responsiveness. HTC cells were incubated in 
suspension culture in IM-BSA containing 0.1 PM dexamethasone for 17 hours. 
Insulin was then added to a final concentration of 4 Uq/ml and incubation 
continued for 24 l/2 hours. The medium was then removed by centrifuqation 
and cell pellets were washed 3 times by resuspension in IM-BSA containing 
dexamethasone but not insulin. Washed cell pellets were resuspended in 
IM-BSA containing 0.1 ~.IM dexamethasone. Immediately ('0' time) and after 
2 hours of incubation, fresh insulin (4 uq/ml) was added to a portion of 
the cell culture. Samples were taken at the times indicated for assay of 
AIB transport velocity. 
(A) washed cells incubated in IM-BSA with dexamethasone 
(A) fresh insulin added to 0 or 2 hours 
10 ug/ml, and does bind its own receptor with an affinity consistent with 
its biological potency, it is likely that this hormone exerts its biological 
effect via the insulin receptor (10). Regulation of responsiveness to this 
hormone could, therefore, be accomplished by modulation of the insulin 
receptor (11). 
There is considerable evidence that insulin can regulate the apparent 
concentration and/or affinity of its own receptors (12,131. In IM-9 lymphocytes 
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insulin causes a time-and concentration-dependent decrease in the apparent 
number of insulin receptors (14). These cells, however, have no known 
biological response to insulin and, thus, the significance of down-regulation 
of receptors in this system is unknown. Chronic exposure to physiological 
levels of insulin results in a decreased number of insulin receptors in human 
fibroblasts (15) and in primary cultures of rat hepatocytes (16,17) also. 
In both systems maximal down-regulation has usually been a 50-60% decrease 
in receptor number. It is doubtful that such a decrease could cause the 
complete loss of response to high concentrations of insulin that we observe. 
Similarly, it is unlikely that a decrease in receptor affinity for insulin, 
as reported in adipocytes (181, could explain the total loss of responsiveness 
described here. 
Regulation of hormone responsiveness could also occur by regulation 
at a step distal to the receptor. For example, high concentrations of opiates 
can decrease cellular responsiveness to these agents without decreasing the 
concentration of opiate receptors (19). Karlsson, et. al have recently reported - -- 
that anti-insulin-receptor antibody-induced insulin resistance in 3T3-Ill fatty 
fibroblasts is apparently caused at an early post-receptor step rather than 
by a change in insulin binding (20). 
We report here an experimental system in which long-term insulin exposure 
causes a complete but reversible loss of insulin responsiveness as assessed 
by both enzyme induction and stimulation of amino acid transport. HTC cells 
provide a unique made1 system in which to study the regulation of both the 
biological response to insulin and insulin binding to its receptor. This 
system may allow the elucidation of the mechanism by which insulin regulates 
cellular responsiveness to itself. 
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